{"id":"W2029746624","doi":"10.1093/annonc/mdt459.78","title":"Clinical Trial Using Cancer/Testis Antigen- and/or VEGFR1/2-Derived Peptide-Vaccine Cocktails","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Medicine; Peptide vaccine; Clinical endpoint; Adverse effect; Internal medicine; Vaccination; Adjuvant; Clinical trial; ELISPOT; Cancer; Oncology; Antigen; Immunology; Epitope","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009968275,0.000989469,0.001463976,0.0002823505,0.000423643,0.0009862196,0.0004737351,0.00139038,0.00547716],"category_scores_gemma":[0.0005730592,0.0002868932,0.0007288147,0.0002609429,0.0007674064,0.000672993,0.0002713703,0.002823907,0.001023346],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006401092,"about_ca_system_score_gemma":0.001467083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005374034,"about_ca_topic_score_gemma":0.001029847,"domain_scores_codex":[0.9997141,0.00009201411,0.0000122744,0.00005739702,0.00002581147,0.000098306],"domain_scores_gemma":[0.9997005,0.0000538183,0.000042208,0.00002292156,0.00002335495,0.00015721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.650208,0.05777997,0.002017237,0.001955301,0.001315496,0.0004565485,0.000254211,0.004053119,0.1208094,0.002194762,0.01021431,0.1487417],"study_design_scores_gemma":[0.405751,0.5620213,0.00269199,0.00009429808,0.0005114872,0.0003124393,0.00007124153,0.001382746,0.01457332,0.0006669696,0.01188692,0.00003637329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808167,0.005081218,0.001113254,0.001904596,0.001007328,0.003313779,0.0008711852,0.0001644979,0.005727516],"genre_scores_gemma":[0.9826075,0.002787269,0.001360638,0.001228343,0.0002876447,0.00274645,0.001235133,0.00002431924,0.007722624],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00547716,"threshold_uncertainty_score":0.01832294,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.17028549287461,"score_gpt":0.4426726818134175,"score_spread":0.2723871889388075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}